Clinical usefulness of gefitinib for non-small-cell lung cancer with a double epidermal growth factor receptor mutation

The aim of this study was to investigate whether the pattern of epidermal growth factor receptor (EGFR) gene mutations affects sensitivity to gefitinib treatment. We investigated 44 surgically resected non-small-cell lung cancer (NSCLC) specimens obtained between 2001 and 2012 at the Tokyo Medical U...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Mol Clin Oncol
Päätekijät: OIKAWA, TAKEFUMI, OHIRA, TATSUO, OTANI, KEISHI, HAGIWARA, MASARU, KONAKA, CHIMORI, IKEDA, NORIHIKO
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: D.A. Spandidos 2015
Aiheet:
Articles
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4360862/
https://ncbi.nlm.nih.gov/pubmed/25798262
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2014.455
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia